
AtaCor Medical Launches Global Trial for Extravascular ICD System
AtaCor Medical has enrolled the first patient in its ALARION-EV pivotal trial, testing a new approach to cardiac rhythm management. The study evaluates the investigational Atala™ lead paired with an Abbott pulse generator, aiming to treat ventricular tachyarrhythmias without placing hardware inside the patient’s heart or blood vessels.
























